Health Condition 1: C189- Malignant neoplasm of colon, unspecified Health Condition 2: C229- Malignant neoplasm of liver, not specified as primary or secondary Health Condition 3: C259- Malignant neoplasm of pancreas, unspecified Health Condition 4: C20- Malignant neoplasm of rectum Health Condition 5: C169- Malignant neoplasm of stomach, unspecified Health Condition 6: C569- Malignant neoplasm of unspecifiedovary Health Condition 7: C55- Malignant neoplasm of uterus, partunspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult (Age 18 and above) 2. Giving informed consent 3. ASA PS 1, 2, 3 4. Planned for surgeries routinely requiring radial artery cannulation and the FlotracTM and Vigileo EV1000 / Volumeview cardiac output monitor for perioperative care used as a part of routine intraoperative management
Exclusion criteria
Exclusion criteria: 1. Planned for open thoracic surgery 2. History of Cardiac arrhythmias/ intraoperative Cardiac arrhythmias 3. Heart failure: both systolic and diastolic heart failure (with or without reduced Left ventricular ejection fraction) 4. Severe restrictive/obstructive lung disease (MRC score 3 and above)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to determine whether the delta ETCO2 after a fluid challenge test identifies fluid responsiveness, i.e., increase in stroke volume index (dSVI) and Cardiac Index (dCI) 10%.Timepoint: After 1 minute of fluid boluses over 10 minutes. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the ability to delta ETCO2 to discriminate between fluid responders and non-responders with that of PPV and Stroke Volume Variation (SVV)Timepoint: After 1 minute of fluid boluses over 10 minutes. | — |
Countries
India
Contacts
Tata Memorial Hospital, Mumbai